Articles

The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.

Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions 

These models are useful in predicting whether an unknown substance of abuse can permeate the BBB to produce effects predicted by the Public Health Assessment via Structural Evaluation (PHASE) approach.

New QSAR Model for Predicting Blood Brain Barrier Permeability

The recent revision is intended to provide guidance on QRM principles and tools that can be used for different aspects of pharmaceutical quality. 

ICH Q9(R1) Quality Risk Management Guidance Document Available

Presspart will still be responsible for the manufacturing of the Sunriser device.

Hovione and H&T Presspart Extend Partnership for Dry Powder Inhalation Formulation Delivery 

mRNA therapeutics are being researched to support the fight against rare diseases, infectious viruses, and cancers.

Arranta Bio Signs Contract with MIT for Rapid mRNA Manufacturing Therapeutics

Cheryl Barton is director of PharmaVision, 

Competition in the organ-on-a-chip market increases as NETRI enters the arena.

Frontrunner in Organ-on-a-Chip

This specific guidance refers to a DCT as a clinical trial where some or all the trial-related activities occur at locations other than traditional clinical trial sites.



FDA Gives Guidance for Decentralized Clinical Trials for Drugs, Devices

The new research and development capacities set the stage for completion of product development for LEON’s manufacturing devices and will be used to showcase the devices and provide process development services to clients using LEON’s equipment.

LEON Sets Lab Facilities at IZB in Munich

The acquisition was completed through the merger of a wholly owned subsidiary of Sanofi with and into Provention Bio.

Sanofi Acquires Provention Bio 

Feliza Mirasol is the science editor for 

INTERPHEX was back in full swing with Keynote sessions highlighting cutting-edge technologies that are setting the stage for the bio/pharma industry’s future.

News